Clinical Trials Browser

OTHER × Liver Neoplasms × Remifentanil × Clear all

NCT06003218 2025-04-02

Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation

Phase NA Completed

Gastrointestinal

Liver Neoplasms